1332581-19-7

Basic information

• Product Name: 2-Methoxy-6-(MethylaMino)benzonitrile
• Synonyms: 2-Methoxy-6-(MethylaMino)benzonitrile;Benzonitrile, 2-Methoxy-6-(MethylaMino)-
• CAS NO: 1332581-19-7
• Molecular Formula: C9H10N2O
• Molecular Weight: 162.1885
• Mol File: 1332581-19-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Methoxy-6-(MethylaMino)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methoxy-6-(MethylaMino)benzonitrile(1332581-19-7)
• EPA Substance Registry System: 2-Methoxy-6-(MethylaMino)benzonitrile(1332581-19-7)

Safety Data

• Hazardous Substances Data: 1332581-19-7(Hazardous Substances Data)

Usage

General Description

2-Methoxy-6-(MethylaMino)benzonitrile is a chemical compound with the molecular formula C9H10N2O. It is a nitrile derivative with a methoxy group and a methylamino group attached to a benzene ring. 2-Methoxy-6-(MethylaMino)benzonitrile is commonly used in the synthesis of pharmaceuticals and agrochemicals due to its versatile reactivity and functional groups. It is also known for its potential use in organic and pharmaceutical chemistry as a reagent and intermediate. Additionally, it has been studied for its potential biological activity, particularly as an inhibitor of certain enzymes. Overall, 2-Methoxy-6-(MethylaMino)benzonitrile is a versatile and potentially valuable chemical compound for various applications in the field of chemistry and biochemistry.

Upstream product

• 94088-46-7 2-fluoro-6-methoxybenzonitrile 
• 74-89-5 methylamine 
• 1897-52-5 2,6 difluorobenzonitrile 
• 124-41-4 sodium methylate 

Relevant articles and documents

Nickel/Photo-Cocatalyzed Asymmetric Acyl-Carbamoylation of Alkenes

An unprecedented asymmetric acyl-carbamoylation of pendant alkenes tethered on aryl carbamic chlorides with both aliphatic and aromatic aldehydes has been developed via the cooperative catalysis of a chiral nickel-PHOX complex and tetrabutylammonium decatungstate. This reaction represents the first example of merging hydrogen-atom-transfer photochemistry and asymmetric transition metal catalysis in difunctionalization of alkenes. Using this protocol, a variety of oxindoles bearing a challenging quaternary stereogenic center are furnished under mild conditions in highly enantioselective manner.

QUINOLINE DERIVATIVES

The invention is related to compounds of general formula (I), wherein R is methyl, ethyl, n-propyl, iso-propyl, n-butyl or allyl; R' is methyl, methoxy, fluoro, chloro, bromo, trifluoromethyl, or OCHxFy, wherein x = O - 2, y = 1 - 3 with the proviso that x + y = 3; R'' is hydrogen, fluoro or chloro; with the proviso that R'' is fluoro or chloro only when R' is fluoro; R4 is hydrogen or pharmaceutically acceptable inorganic or organic cations; R5 is ethyl, n-propyl, iso-propyl, methoxy, ethoxy, chloro, bromo, trifluoromethyl, OCHxFy, or OCH2CHxFy wherein x = 0 - 2, y = 1 - 3 with the proviso that x + y = 3; R6 is hydrogen; or R5, and R6 taken together are methylenedioxy; and any tautomer thereof. The invention also relates to pharmaceutical compositions containing a compound of general formula (I) together with a pharmaceutically acceptable carrier. Included are also processes for the preparation of the compounds of formula (I), as well as methods for the treatment of mammals suffering from diseases resulting from autoimmunity and pathological inflammation by administering of a compound having formula (I) to said mammal.